Advertisement

Topics

Mid-FDA Review, Tetraphase Stumbles Again on Latest Phase 3 Setback

07:57 EST 14 Feb 2018 | Xconomy

Tetraphase Pharmaceuticals’ ups and downs have continued, as new data have clouded the future of the Watertown, MA, company’s experimental antibiotic, eravacycline, once again. Tetraphase (NASDAQ: TTPH) reported that eravacycline failed a 1,200-patient Phase 3 study called Ignite3, one of four late-stage trials the company ran to test the antibiotic against either complicated urinary tract […]

Original Article: Mid-FDA Review, Tetraphase Stumbles Again on Latest Phase 3 Setback

NEXT ARTICLE

More From BioPortfolio on "Mid-FDA Review, Tetraphase Stumbles Again on Latest Phase 3 Setback"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Urology
Benign Prostatic Hyperplasia (BPH) Erectile Dysfunction Urology Urology is the branch of medicine concerned with the urinary tract and diseases that affect it. Examples include urethritis, urethrostenosis and incontinence. Urology is a su...